Remedy Meds is buying Thirty Madison, a virtual care startup that competes with the likes of Hims and Ro.
Remedy Meds, which sells GLP-1 weight loss medications and provides telehealth services directly to consumers, will ….
Author: PharmaSignal News Desk
Deal includes global rights to cancer therapies. $200M upfront payment by Servier to Ideaya.
A biotech co-founded by Nobel laureate David Baker has reeled in an $80 million Series B to get into the clinic early next year with an AI-designed cancer drug.
Alnylam Pharmaceuticals said it will start a Phase 3 cardiovascular outcomes trial of its hypertension therapy zilebesiran this year, despite data showing the drug failed in a mid-stage study.
The end of Covid vaccine emergency authorizations may limit the availability of shots for young, healthy kids.
AbbVie agreed to pay up to $1.2 billion to buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major depression
Zydus Therapeutics’ PBC data: The drug saroglitazar met the primary endpoint in a Phase 2b/3 trial for a rare autoimmune disease that affects the bile ducts, the …
CVS Health will not add Gilead Sciences’ new HIV prevention drug to its commercial plans for now, despite the medicine’s proven effectiveness
The vaccine is approved for adults aged 65 years and older and individuals aged 5 to 64 years with underlying conditions
The authorised generic of Carac (fluorouracil cream) 0.5 per cent is approved by the USFDA and manufactured in Texas for the treatment of actinic keratoses